Literature DB >> 9538572

Susceptibility of selected strains of Australian mosquitoes (Diptera: Culicidae) to Rift Valley fever virus.

M J Turell1, B H Kay.   

Abstract

We evaluated the ability of selected strains of the Australian mosquitoes, Aedes notoscriptus (Skuse), Ae. vigilax (Skuse), Culex annulirostris Skuse, and Cx. quinquefasciatus Say, to function as potential vectors of Rift Valley fever (RVF) virus, should that virus be introduced accidentally into Australia. After feeding on a hamster with a viremia of 10(7) plaque-forming units/ml of blood, Ae. notoscriptus and Cx. annulirostris were the most susceptible, with infection rates of 86 and 55%, respectively. Female Ae. vigilax and Cx. quinquefasciatus also were susceptible, with infection rates of 38 and 30%, respectively. All of these species transmitted RVF virus by bite 7-10 d after intrathoracic inoculation, and all, except Cx. quinquefastiatus (not tested), transmitted RVF virus 10-16 d after oral exposure. The presence of competent mosquito vectors for RVF virus in Australia indicates the potential for RVF virus epizootics to occur should this virus be introduced into Australia.

Entities:  

Mesh:

Year:  1998        PMID: 9538572     DOI: 10.1093/jmedent/35.2.132

Source DB:  PubMed          Journal:  J Med Entomol        ISSN: 0022-2585            Impact factor:   2.278


  15 in total

1.  Genetic reassortment of Rift Valley fever virus in nature.

Authors:  A A Sall; P M Zanotto; O K Sene; H G Zeller; J P Digoutte; Y Thiongane; M Bouloy
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

Review 2.  A review of mosquitoes associated with Rift Valley fever virus in Madagascar.

Authors:  Luciano M Tantely; Sébastien Boyer; Didier Fontenille
Journal:  Am J Trop Med Hyg       Date:  2015-03-02       Impact factor: 2.345

3.  Reagents for detection of Rift Valley fever virus infection in sheep.

Authors:  Brian J Shiell; Siying Ye; Jennifer A Harper; Brenda van der Heide; Gary Beddome; Adam J Foord; Wojtek P Michalski; John Bingham; Grantley R Peck
Journal:  J Vet Diagn Invest       Date:  2020-05-25       Impact factor: 1.279

Review 4.  Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.

Authors:  Michele Bouloy; Ramon Flick
Journal:  Antiviral Res       Date:  2009-08-12       Impact factor: 5.970

5.  A novel system for identification of inhibitors of rift valley Fever virus replication.

Authors:  Mary E Piper; Sonja R Gerrard
Journal:  Viruses       Date:  2010-03-18       Impact factor: 5.818

Review 6.  Evolution of mosquito-based arbovirus surveillance systems in Australia.

Authors:  Andrew F van den Hurk; Sonja Hall-Mendelin; Cheryl A Johansen; David Warrilow; Scott A Ritchie
Journal:  J Biomed Biotechnol       Date:  2012-03-11

7.  A Stochastic Model to Study Rift Valley Fever Persistence with Different Seasonal Patterns of Vector Abundance: New Insights on the Endemicity in the Tropical Island of Mayotte.

Authors:  Lisa Cavalerie; Maud V P Charron; Pauline Ezanno; Laure Dommergues; Betty Zumbo; Eric Cardinale
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

8.  Vector competence of Aedes vexans (Meigen), Culex poicilipes (Theobald) and Cx. quinquefasciatus Say from Senegal for West and East African lineages of Rift Valley fever virus.

Authors:  El Hadji Ndiaye; Gamou Fall; Alioune Gaye; Ndeye Sakha Bob; Cheikh Talla; Cheikh Tidiane Diagne; Diawo Diallo; Yamar B A; Ibrahima Dia; Alain Kohl; Amadou Alpha Sall; Mawlouth Diallo
Journal:  Parasit Vectors       Date:  2016-02-20       Impact factor: 3.876

9.  An epidemiological model of Rift Valley fever with spatial dynamics.

Authors:  Tianchan Niu; Holly D Gaff; Yiannis E Papelis; David M Hartley
Journal:  Comput Math Methods Med       Date:  2012-08-13       Impact factor: 2.238

10.  A hierarchical network approach for modeling Rift Valley fever epidemics with applications in North America.

Authors:  Ling Xue; Lee W Cohnstaedt; H Morgan Scott; Caterina Scoglio
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.